Disease | hematopoietic stem cell transplantation |
Phenotype | C0039730|thalassemia |
Sentences | 9 |
PubMedID- 22645178 | Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan. |
PubMedID- 20979169 | hematopoietic stem cell transplantation for children with thalassemia major in china. |
PubMedID- 25017762 | Impact of beta-globin mutations on outcome of matched related donor hematopoietic stem cell transplantation for patients with beta-thalassemia major. |
PubMedID- 19897573 | These results suggest that maternal haploidentical hematopoietic stem cell transplantation is feasible in patients with thalassemia who lack a matched related donor. |
PubMedID- 22553502 | hematopoietic stem cell transplantation in thalassemia and sickle cell anemia. |
PubMedID- 22588927 | Objective: to investigate the effects of different doses of antithymocyte globubin-fresenius (atg-f) for allogeneic hematopoietic stem cell transplantation (allo-hsct) in patients with beta-thalassemia major. |
PubMedID- 25793043 | Objective: thalassemia along with hematopoietic stem cell transplantation (hsct) can lead to major oxidative stress. |
PubMedID- 24790059 | hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel. |
PubMedID- 21239835 | This review provides a brief history of hematopoietic stem cell transplantation in thalassemia and reassesses current clinical results with the objective to provide outcome predictions based on modern transplant technologies. |
Page: 1